<DOC>
	<DOCNO>NCT02275923</DOCNO>
	<brief_summary>The purpose study investigate use subcutaneous impedance measure implanted Medtronic Reveal LINQ™ insertable cardiac monitor use fluid status monitor hemodialysis patient . The study measure change subject subcutaneous impedance compare fluid status assess volume remove hemodialysis subject dialysis session . Subcutaneous impedance trend also evaluate dialysis session .</brief_summary>
	<brief_title>Reveal LINQ™ Evaluation Fluid</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients currently undergo inclinic hemodialysis treatment prescribe 2 3 time per week Patients willing implanted Reveal LINQ™ device Patients great 21 year age Patients willing able comply study procedure include give informed consent Patient active implanted cardiac medical device ( e.g . IPG , ICD , CRT , etc ) Patients currently undergo home dialysis treatment Patient enrol another study could confound result study , without document preapproval Medtronic study manager . Patient recent infection define 1 ) bacteremia within 60 day OR 2 ) ( nonbacteremic ) infection within 14 day Patient suitable Reveal LINQ™ implantation ( e.g. , severe cachexia , dermatologic condition skin , major medical social condition expect reduce survival &lt; 6 month ) , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>